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Abstract
Introduction: The association of Guillain-Barré syndrome with vaccination has been described in the literature; it is
infrequent and controversial. An association with swine influenza, influenza, hepatitis and tetanus vaccination has
been documented in few case reports.
Case presentation: A 40-year-old Caucasian man sustained a small right temporal epidural hematoma and
nondisplaced right skull fractures after a fall from a roof. He was managed conservatively; a tetanus toxoid, reduced
diphtheria toxoid and acellular pertussis vaccine was administered and a week later he was discharged home. A
few days after his discharge, he experienced weakness and numbness in his legs, which progressed to involve his
arms. Three weeks after his initial fall, he was readmitted with quadriparesis. A lumbar puncture revealed a
cerebrospinal fluid protein of 790 mg/dL and one white blood cell. We diagnosed Guillain-Barré syndrome. Our
patient was treated with intravenous immunoglobulin. Three months later his muscle strength had improved, but
he continued to have tingling in his hands and feet and used a walker intermittently.
Conclusion: To the best of our knowledge, this is the first case of Guillain-Barré syndrome to be reported in the
English literature after administration of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine.
Introduction
The association of Guillain-Barré syndrome (GBS) with
vaccination has been described but is infrequent and, in
many settings, is controversial. A small but statistically
significant elevated risk of GBS was noted among swine
flu vaccinees relative to non vaccinees in 1976 [1].
The influenza vaccine in the 1992 to 1994 vaccine
campaign was associated with a very small increased
risk, of one GBS case per million vaccinees. Hepatitis
vaccinations were also suggested to be associated with
GBS [1]. The association of tetanus vaccination and
GBS is documented in only a few case reports (1-5).
Case presentation
A 40-year-old Caucasian man fell from a second story
roof. He sustained a small right temporal epidural
hematoma, a nondisplaced right temporal scalp fracture
and a zygomatic arch fracture. His neurological exami-
nation was normal.
A tetanus toxoid, reduced diphtheria toxoid and acel-
lular pertussis vaccine (Tdap; Boostrix) was adminis-
tered. He was managed conservatively and discharged
home one week later.
A few days after his discharge, our patient experienced
weakness and numbness in his legs, which progressed to
involve his arms. Three weeks after his initial fall, he
was readmitted to our hospital with severe weakness.
His muscle strength was 2/5 in his lower extremities
and 3/5 in his upper extremities. His deep tendon
reflexes were absent at his ankles and knees and were
diminished in his upper extremities. There was bilateral
peripheral facial paresis, bulbar weakness and impaired
gag reflex. He had diminished touch and pin prick sen-
sation in a stocking glove distribution.
His vital capacity was reduced to 1.4 liters. Magnetic
resonance imaging of his brain and spinal cord were
unremarkable. A lumbar puncture revealed a Correspondence: hussam.m.ammar@uth.tmc.edu
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blood cell.
We diagnosed GBS. Nerve conduction studies revealed
prolongation of the upper and lower motor action
potential latencies, reduced motor conduction velocities
and reduced amplitude. Median and ulnar nerves sen-
sory action potentials were absent. Our patient was trea-
ted with intravenous immunoglobulin and his muscle
strength improved. Three months later he continued to
have tingling in his hands and feet and use a walker
intermittently.
Discussion
The association of tetanus toxoid containing vaccines
and GBS is documented in a small number of case
reports, outlined in Table 1[1-5].
The Advisory Committee on Immunization Practice
considers development of GBS less than six weeks after
receiving a tetanus toxoid-containing vaccine a precau-
tion for subsequent tetanus toxoid-containing
vaccinations.
The Institute of Medicine favored the acceptance of
causal relationship between tetanus toxoid-containing
vaccine and GBS based on a single documented case
report [2]. A subsequent analysis estimated the number
of cases of GBS observed after a tetanus toxoid-contain-
ing vaccine to be less than the number caused by
chance alone [1,2].
Our patient didn’t have diarrhea, fever, cough or chills
in the weeks preceding his illness. The only recognized
event was receiving the Tdap vaccine one week before
his illness.
Conclusion
To the best of our knowledge, this is the first case of
GBS to be reported in the English literature after
administration of a Tdap vaccine.
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Table 1 Cases describing the association of tetanus vaccination and GBS
Case Tetanus
containing
vaccine
Onset of
symptoms
after
vaccination
Clinical presentation Treatment Outcome
[3] Tetanus toxoid
(1962,1971,1976)
First episode:
three weeks
First episode: Progressive limb weakness. CSF was
normal except a protein level of 300 mg/dL.
Symptomatic
treatment and
physical therapy.
First episode: Complete recovery
after two months.
Second
episode: two
weeks
Second episode: Tingling and numbness, mild
weakness, loss of position sense, absent DTR. CSF
was normal except a protein level of 250 mg/dL.
Second episode: Recovery after
eight months with slight hand
tremors.
Third episode:
10 days
Third episode: Tingling and numbness, unable to
walk, loss of position sense and diminished pin prick
sensation below knees.
Third episode: Patient had only
mild hand weakness by day 12.
[4] Tetanus toxoid. Nine days Tingling and numbness, profound weakness of the
extremities, bilateral peripheral facial paresis, bulbar
weakness, bilateral weakness of ocular abduction.
DTR were absent. Touch and pin prick sensation
were diminished distally in lower extremities. Vital
capacity was 1.6 L. CSF protein level was 550 mg/dL,
no pleocytosis.
Symptomatic
treatment and
physical therapy
Discharge after 57 days with
mild left leg weakness.
[5] Tetanus toxoid. Four days Tingling of finger tips and toes, moderate weakness
of four extremities. DTR were absent at ankles, knees
and triceps. There was bilateral facial weakness and
dysphagia. Position and vibration sense was
diminished distally in four extremities. CSF protein
level was 70 mg/dL.
Intravenous
immunoglobulin
and physical
therapy
Significant improvement at six
weeks. Residual facial weakness
and painful twitching in both
arms.
CSF: cerebrospinal fluid; DTR: deep tendon reflexes
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